STAT

‘We’re flying blind’: African Americans may be bearing the brunt of Covid-19, but access to data are limited

The widening racial divide in who gets infected, who gets tested, and who dies from Covid-19 is emerging from the few cities and states whose data is public.

Stark statistics are coming to light only now and only in piecemeal fashion showing that African Americans are disproportionately affected by Covid-19. The racial divide in who gets infected, who gets tested, and who dies from Covid-19 is emerging from the few cities and states whose data are public.

African Americans in Illinois, for example, accounted for 29% of confirmed cases and 41% of deaths as of Monday morning, yet they make up only 15% of the state’s population, according to the Illinois Department of Public Health, one of just a handful of government agencies sharing first reported that African Americans number nearly half of the 941 cases in Milwaukee County and 81% of its 27 deaths while the population is 26% African American.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks